Literature DB >> 9388260

The protein-tyrosine phosphatase SHP-2 associates with tyrosine-phosphorylated adhesion molecule PECAM-1 (CD31).

K Sagawa1, T Kimura, M Swieter, R P Siraganian.   

Abstract

Aggregation of many cell-surface receptors results in tyrosine phosphorylation of numerous proteins. We previously observed the tyrosine phosphorylation of the platelet/endothelial cell adhesion molecule, PECAM-1 (CD31), after FcepsilonRI stimulation in rat basophilic leukemia RBL-2H3 cells. Here we found that PECAM-1 was also transiently tyrosine-phosphoryated after adherence of these cells to fibronectin. Similarly aggregation of the T cell receptor on Jurkat cells also induced this tyrosine phosphorylation. The protein-tyrosine phosphatase SHP-2 is a widely expressed cytosolic enzyme with two Src homology 2 (SH2) domains. SHP-2, but not the related protein-tyrosine phosphatase SHP-1, associated with PECAM-1. This association of the two proteins correlated with the extent of the tyrosine phosphorylation of PECAM-1. A fusion protein containing the two SH2 domains of SHP-2 precipitated PECAM-1 from cell lysates and also directly bound to phosphorylated PECAM-1. In immune precipitate phosphatase assays, there was tyrosine dephosphorylation of PECAM-1. Therefore, integrin and immune receptor activation results in tyrosine phosphorylation of PECAM-1 and the binding of the protein-tyrosine phosphatase SHP-2, which could regulate receptor-mediated signaling in cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9388260     DOI: 10.1074/jbc.272.49.31086

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

1.  Morphogenetic movements at gastrulation require the SH2 tyrosine phosphatase Shp2.

Authors:  T M Saxton; T Pawson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

2.  The alleles of PECAM-1.

Authors:  Melanie S Novinska; Bradley C Pietz; Thomas M Ellis; Debra K Newman; Peter J Newman
Journal:  Gene       Date:  2006-04-11       Impact factor: 3.688

3.  CD44: target for antiangiogenesis therapy.

Authors:  Horace M DeLisser
Journal:  Blood       Date:  2009-12-10       Impact factor: 22.113

4.  An alternatively spliced isoform of PECAM-1 is expressed at high levels in human and murine tissues, and suggests a novel role for the C-terminus of PECAM-1 in cytoprotective signaling.

Authors:  Carmen Bergom; Cathy Paddock; Cunji Gao; Trudy Holyst; Debra K Newman; Peter J Newman
Journal:  J Cell Sci       Date:  2008-04-15       Impact factor: 5.285

5.  Switched at birth: a new family for PECAM-1.

Authors:  P J Newman
Journal:  J Clin Invest       Date:  1999-01       Impact factor: 14.808

Review 6.  PECAM-1 isoforms, eNOS and endoglin axis in regulation of angiogenesis.

Authors:  Sunyoung Park; Christine M Sorenson; Nader Sheibani
Journal:  Clin Sci (Lond)       Date:  2015-08       Impact factor: 6.124

7.  Identification of Fer tyrosine kinase localized on microtubules as a platelet endothelial cell adhesion molecule-1 phosphorylating kinase in vascular endothelial cells.

Authors:  Naoko Kogata; Michitaka Masuda; Yuji Kamioka; Akiko Yamagishi; Akira Endo; Masato Okada; Naoki Mochizuki
Journal:  Mol Biol Cell       Date:  2003-06-13       Impact factor: 4.138

8.  Genetic interaction between integrins and moleskin, a gene encoding a Drosophila homolog of importin-7.

Authors:  Scott E Baker; James A Lorenzen; Steven W Miller; Thomas A Bunch; Alison L Jannuzi; Mark H Ginsberg; Lizabeth A Perkins; Danny L Brower
Journal:  Genetics       Date:  2002-09       Impact factor: 4.562

9.  Endothelial Src kinase regulates membrane recycling from the lateral border recycling compartment during leukocyte transendothelial migration.

Authors:  Bidisha Dasgupta; William A Muller
Journal:  Eur J Immunol       Date:  2008-12       Impact factor: 5.532

10.  PECAM-1 expression and activity negatively regulate multiple platelet signaling pathways.

Authors:  Chris I Jones; Stephen F Garner; Leonardo A Moraes; William J Kaiser; Angela Rankin; Willem H Ouwehand; Alison H Goodall; Jonathan M Gibbins
Journal:  FEBS Lett       Date:  2009-10-20       Impact factor: 4.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.